Live from the NIH registry
Studies recruiting near Lincoln right now
Top 25 of 159 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Physician Research Collaboration — Lincoln, Nebraska (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Insomnia Disorder
Phase 3
Interventional 420 participants sought
Vanda Investigational Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: Vanda Pharmaceuticals
Abbott Vascular Medical Device Registry
Acute Myocardial Infarction, Restenoses, Coronary
N/A
Observational 3,784 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: Abbott Medical Devices
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS)
Phase 2
Interventional 240 participants sought
Zydus US014 — Lincoln, Nebraska (0.9 mi)
· Sponsor: Zydus Therapeutics Inc.
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Jazz Pharmaceuticals
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Bryan Health Pine Lake Campus /ID# 259638 — Lincoln, Nebraska (0.9 mi)
· Sponsor: AbbVie
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Midwest Children's Health Research Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Lincoln — Lincoln, Nebraska (0.9 mi)
· Sponsor: Sparrow Pharmaceuticals
Investigating the Effects of Beef Consumption on Cognitive and Brain Health
Dietary Intervention, Dietary Proteins
N/A
Interventional 240 participants sought
University of Nebraska-Lincoln — Lincoln, Nebraska (0.9 mi)
· Sponsor: University of Nebraska Lincoln
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 490 participants sought
Nho - Revive Research Institute /ID# 277569 — Lincoln, Nebraska (0.9 mi)
· Sponsor: AbbVie
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Phase 3
Interventional 500 participants sought
NHO Revive Research Institute, LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Clonal Mast Cell Disease, KIT D816V Mutation
N/A
Observational 750 participants sought
Somnos Clinical Research — Lincoln, Nebraska (0.9 mi)
· Sponsor: Blueprint Medicines Corporation
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 120 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Cancer Partners of Nebraska April Sampson Cancer Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: BeOne Medicines
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: Amgen
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
High-risk Muscle Invasive Urothelial Carcinoma
Phase 3
Interventional 915 participants sought
Research Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: AstraZeneca
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: AstraZeneca
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Atopic Dermatitis
Phase 3
Interventional 200 participants sought
Physician Research Collaboration, LLC /ID# 263583 — Lincoln, Nebraska (0.9 mi)
· Sponsor: AbbVie
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Bipolar Depression
Phase 3
Interventional 384 participants sought
Alivation Research LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: AstraZeneca
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
Pneumococcal Disease
Phase 3
Interventional 1,200 participants sought
Midwest Children's Health Research Institute — Lincoln, Nebraska (0.9 mi)
· Sponsor: Pfizer
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: DalCor Pharmaceuticals
Effectiveness of Plaque Score Detection Techniques
Plaque, Dental
N/A
Observational 50 participants sought
University of Nebraska Medical Center Dental College — Lincoln, Nebraska (0.9 mi)
· Sponsor: University of Nebraska